Advances in Neurocritical Care and the Significance of the SWITCH Trial

It is unknown whether decompressive craniectomy improves clinical outcome for people with spontaneous severe deep intracerebral haemorrhage. The SWITCH trial aimed to assess whether decompressive craniectomy plus best medical treatment in these patients improves outcome at 6 months compared to best medical treatment alone. The SWITCH Trial has come to an end and the findings published in The Lancet and in this week's HOT TOPICS episode, Dr. Nicholas Morris is joined by two of the lead authors, Prof. Jürgen Beck, MD and Prof. Urs Fischer, MD to discuss the trial.